Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Cencora is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-09-25Current report (material event)
- 8-K2026-08-14Current report (material event)
- 8-K2026-08-12Current report (material event)
- 10-Q2026-08-05Quarterly report
- 8-K2026-08-05Current report (material event)
- 8-K2026-08-05Current report (material event)
- 11-K2026-06-1811-K
- 8-K2026-06-15Current report (material event)
- 8-K2026-05-29Current report (material event)
- SD2026-05-29SD
- 10-Q2026-05-06Quarterly report
- 8-K2026-05-06Current report (material event)
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- 8-K2026-03-23Current report (material event)
- 8-K2026-03-17Current report (material event)
- 8-K2026-03-06Current report (material event)
- 8-K2026-02-18Current report (material event)
- 8-K2026-02-13Current report (material event)
- 424B22026-02-11424B2
- 8-K2026-02-11Current report (material event)
- FWP2026-02-10FWP
- 424B52026-02-10Prospectus (offering)
- 8-K2026-02-10Current report (material event)
- 10-Q2026-02-04Quarterly report
- 8-K2026-02-04Current report (material event)
- ARS2026-01-22Annual report to holders
- DEFA14A2026-01-22DEFA14A
- DEF 14A2026-01-22Proxy statement
- 8-K2026-01-22Current report (material event)
- 8-K2026-01-16Current report (material event)
- 8-K2025-12-15Current report (material event)
- 10-K2025-11-25Annual report
- 8-K2025-11-05Current report (material event)
- 8-K2025-09-09Current report (material event)
- 8-K2025-09-03Current report (material event)
- 8-K2025-08-27Current report (material event)
- 10-Q2025-08-06Quarterly report
- 8-K2025-08-06Current report (material event)
- SCHEDULE 13G/A2025-07-29SCHEDULE 13G/A
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.